ELV or DHR: Which Is the Better Value Stock Right Now?

In a comparison of two Medical Services stocks, Elevance Health (ELV) emerges as the superior value option over Danaher (DHR). ELV holds a Zacks Rank of #2 (Buy) with a Value grade of A, featuring a forward P/E of 15.70 and PEG ratio of 2.22. DHR has a Zacks Rank of #3 (Hold) with a Value grade of D, with a forward P/E of 23.84 and PEG ratio of 2.53. Based on valuation metrics and earnings outlook, ELV is positioned as the better value investment.